FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058230478> ?p ?o ?g. }

• W2058230478 abstract "Overexpression of the ERBB2 oncogene is observed in about 20% of human breast tumors and is the consequence of increased transcription rates frequently associated with gene amplification. Several studies have shown a link between activator protein 2 (AP-2) transcription factors and ERBB2 gene expression in breast cancer cell lines. Moreover, the Yin Yang 1 (YY1) transcription factor has been shown to stimulate AP-2 transcriptional activity on the ERBB2 promoter in vitro. In this report, we examined the relationships between ERBB2, AP-2α, and YY1 both in breast cancer tissue specimens and in a mammary cancer cell line. ERBB2, AP-2α, and YY1 protein levels were analyzed by immunohistochemistry in a panel of 55 primary breast tumors. ERBB2 gene amplification status was determined by fluorescent in situ hybridization. Correlations were evaluated by a χ2 test at a p value of less than 0.05. The functional role of AP-2α and YY1 on ERBB2 gene expression was analyzed by small interfering RNA (siRNA) transfection in the BT-474 mammary cancer cell line followed by real-time reverse transcription-polymerase chain reaction and Western blotting. We observed a statistically significant correlation between ERBB2 and AP-2α levels in the tumors (p < 0.01). Moreover, associations were found between ERBB2 protein level and the combined high expression of AP-2α and YY1 (p < 0.02) as well as between the expression of AP-2α and YY1 (p < 0.001). Furthermore, the levels of both AP-2α and YY1 proteins were inversely correlated to ERBB2 gene amplification status in the tumors (p < 0.01). Transfection of siRNAs targeting AP-2α and AP-2γ mRNAs in the BT-474 breast cancer cell line repressed the expression of the endogenous ERBB2 gene at both the mRNA and protein levels. Moreover, the additional transfection of an siRNA directed against the YY1 transcript further reduced the ERBB2 protein level, suggesting that AP-2 and YY1 transcription factors cooperate to stimulate the transcription of the ERBB2 gene. This study highlights the role of both AP-2α and YY1 transcription factors in ERBB2 oncogene overexpression in breast tumors. Our results also suggest that high ERBB2 expression may result either from gene amplification or from increased transcription factor levels." @default.
• W2058230478 created "2016-06-24" @default.
• W2058230478 creator A5001231312 @default.
• W2058230478 creator A5007863325 @default.
• W2058230478 creator A5011025859 @default.
• W2058230478 creator A5017406815 @default.
• W2058230478 creator A5025624026 @default.
• W2058230478 creator A5027485749 @default.
• W2058230478 creator A5035800768 @default.
• W2058230478 creator A5046893286 @default.
• W2058230478 creator A5065927504 @default.
• W2058230478 creator A5075530548 @default.
• W2058230478 date "2008-01-24" @default.
• W2058230478 modified "2023-10-16" @default.
• W2058230478 title "The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors" @default.
• W2058230478 cites W1525133146 @default.
• W2058230478 cites W1550092936 @default.
• W2058230478 cites W1590222977 @default.
• W2058230478 cites W1611419331 @default.
• W2058230478 cites W1685536199 @default.
• W2058230478 cites W187705992 @default.
• W2058230478 cites W1964321121 @default.
• W2058230478 cites W1976121925 @default.
• W2058230478 cites W1980286986 @default.
• W2058230478 cites W1982288359 @default.
• W2058230478 cites W1986744382 @default.
• W2058230478 cites W1997155687 @default.
• W2058230478 cites W2008661555 @default.
• W2058230478 cites W2032694158 @default.
• W2058230478 cites W2036058546 @default.
• W2058230478 cites W2041803642 @default.
• W2058230478 cites W2044735117 @default.
• W2058230478 cites W2044766101 @default.
• W2058230478 cites W2067276829 @default.
• W2058230478 cites W2086132669 @default.
• W2058230478 cites W2092552038 @default.
• W2058230478 cites W2105872656 @default.
• W2058230478 cites W2108754630 @default.
• W2058230478 cites W2113556902 @default.
• W2058230478 cites W2126937732 @default.
• W2058230478 cites W2130900820 @default.
• W2058230478 cites W2130923413 @default.
• W2058230478 cites W2145084871 @default.
• W2058230478 cites W2158301564 @default.
• W2058230478 doi "https://doi.org/10.1186/bcr1851" @default.
• W2058230478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2374961" @default.
• W2058230478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18218085" @default.
• W2058230478 hasPublicationYear "2008" @default.
• W2058230478 type Work @default.
• W2058230478 sameAs 2058230478 @default.
• W2058230478 citedByCount "86" @default.
• W2058230478 countsByYear W20582304782012 @default.
• W2058230478 countsByYear W20582304782013 @default.
• W2058230478 countsByYear W20582304782014 @default.
• W2058230478 countsByYear W20582304782015 @default.
• W2058230478 countsByYear W20582304782016 @default.
• W2058230478 countsByYear W20582304782017 @default.
• W2058230478 countsByYear W20582304782018 @default.
• W2058230478 countsByYear W20582304782019 @default.
• W2058230478 countsByYear W20582304782020 @default.
• W2058230478 countsByYear W20582304782021 @default.
• W2058230478 countsByYear W20582304782022 @default.
• W2058230478 countsByYear W20582304782023 @default.
• W2058230478 crossrefType "journal-article" @default.
• W2058230478 hasAuthorship W2058230478A5001231312 @default.
• W2058230478 hasAuthorship W2058230478A5007863325 @default.
• W2058230478 hasAuthorship W2058230478A5011025859 @default.
• W2058230478 hasAuthorship W2058230478A5017406815 @default.
• W2058230478 hasAuthorship W2058230478A5025624026 @default.
• W2058230478 hasAuthorship W2058230478A5027485749 @default.
• W2058230478 hasAuthorship W2058230478A5035800768 @default.
• W2058230478 hasAuthorship W2058230478A5046893286 @default.
• W2058230478 hasAuthorship W2058230478A5065927504 @default.
• W2058230478 hasAuthorship W2058230478A5075530548 @default.
• W2058230478 hasBestOaLocation W20582304781 @default.
• W2058230478 hasConcept C101762097 @default.
• W2058230478 hasConcept C104317684 @default.
• W2058230478 hasConcept C121608353 @default.
• W2058230478 hasConcept C150194340 @default.
• W2058230478 hasConcept C153911025 @default.
• W2058230478 hasConcept C22615655 @default.
• W2058230478 hasConcept C2781018059 @default.
• W2058230478 hasConcept C29537977 @default.
• W2058230478 hasConcept C502942594 @default.
• W2058230478 hasConcept C530470458 @default.
• W2058230478 hasConcept C54009773 @default.
• W2058230478 hasConcept C54355233 @default.
• W2058230478 hasConcept C62944979 @default.
• W2058230478 hasConcept C86339819 @default.
• W2058230478 hasConcept C86803240 @default.
• W2058230478 hasConcept C88045685 @default.
• W2058230478 hasConceptScore W2058230478C101762097 @default.
• W2058230478 hasConceptScore W2058230478C104317684 @default.
• W2058230478 hasConceptScore W2058230478C121608353 @default.
• W2058230478 hasConceptScore W2058230478C150194340 @default.
• W2058230478 hasConceptScore W2058230478C153911025 @default.
• W2058230478 hasConceptScore W2058230478C22615655 @default.
• W2058230478 hasConceptScore W2058230478C2781018059 @default.
• W2058230478 hasConceptScore W2058230478C29537977 @default.
• W2058230478 hasConceptScore W2058230478C502942594 @default.

• next